Appraisal of subclinical symptomatology in depression has important implications for pathophysiological models of disease and relapse prevention. New therapeutic strategies for improving the level of remission, such as treatment on residual symptoms that progress to become prodromes of relapse, may yield more lasting benefits.
No takes yet. Share an insight, caveat, or question.
Fava et al. (2006) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: